Cargando…
RK‐287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model
Aberrant activation of Wnt/β‐catenin signaling causes tumorigenesis and promotes the proliferation of colorectal cancer cells. Porcupine inhibitors, which block secretion of Wnt ligands, may have only limited clinical impact for the treatment of colorectal cancer, because most colorectal cancer is c...
Autores principales: | Mizutani, Anna, Yashiroda, Yoko, Muramatsu, Yukiko, Yoshida, Haruka, Chikada, Tsubasa, Tsumura, Takeshi, Okue, Masayuki, Shirai, Fumiyuki, Fukami, Takehiro, Yoshida, Minoru, Seimiya, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272098/ https://www.ncbi.nlm.nih.gov/pubmed/30238564 http://dx.doi.org/10.1111/cas.13805 |
Ejemplares similares
-
mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer
por: Mashima, Tetsuo, et al.
Publicado: (2017) -
The telomeric PARP, tankyrases, as targets for cancer therapy
por: Seimiya, H
Publicado: (2006) -
Tankyrase 1 and Tankyrase 2 Are Essential but Redundant for Mouse Embryonic Development
por: Chiang, Y. Jeffrey, et al.
Publicado: (2008) -
Preclinical Lead
Optimization of a 1,2,4-Triazole
Based Tankyrase Inhibitor
por: Waaler, Jo, et al.
Publicado: (2020) -
FK506-binding protein, FKBP12, promotes serine utilization and negatively regulates threonine deaminase in fission yeast
por: Sasaki, Mayuki, et al.
Publicado: (2022)